Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study

Anouk H. Eijkelboom, Linda de Munck, Marie-Jeanne T. F. D. Vrancken Peeters, Mireille J. M. Broeders, Luc J. A. Strobbe, Monique E. M. M. Bos, Marjanka K. Schmidt, Cristina Guerrero Paez, Marjolein L. Smidt, Maud Bessems, Janneke Verloop, Sabine Linn, Marc B. I. Lobbes, Aafke H. Honkoop, Desiree H. J. G. van den Bongard, Pieter J. Westenend, Jelle Wesseling, C. Willemien van der Houven van Oordt, Vivianne C. G. Tjan-Heijnen, Sabine Siesling*NABON COVID-19 Consortium, NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number64
Number of pages12
JournalJournal of Hematology & Oncology
Volume14
Issue number1
DOIs
Publication statusPublished - 17 Apr 2021

Keywords

  • COVID-19
  • Breast cancer
  • Incidence
  • Screening
  • Treatment
  • Stage
  • Population-based

Cite this